Daniel A. Peisert is CEO & President at Assertio Therapeutics, Inc (ASRT). They have made 9 open-market trades across 1 company since 2019, most recently 2023-09-12.
CIK 0001758376
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $112K since 2019, against 3 sales. Across 6 scored buys the stock is down 21.0% at ninety days, and 27.3 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ASRT | 356,060 | $8.4M |
Shares reported on the most recent Form 4, priced at the 2023-09-13 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 17% | 17% |
| Avg Move | +4.2% | +6.2% | -21.0% |
| Alpha | +3.8% | +3.6% | -27.3% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ASRT | SELL | 2023-09-11 | 2023-09-13 | $3.03 | $959K | -11.6% | -19.9% | -64.0% |
| ASRT | SELL | 2022-04-11 | 2022-04-13 | $3.50 | $185K | -31.0% | -8.6% | -9.7% |
| ASRT | SELL | 2022-04-05 | 2022-04-07 | $3.50 | $121K | -22.7% | -44.5% | -6.2% |
| ASRT | BUY | 2021-05-20 | 2021-05-24 | $1.54 | $24K | +13.2% | +0.0% | -39.4% |
| ASRT | BUY | 2019-11-11 | 2019-11-12 | $0.73 | $7K | -3.0% | +61.8% | +78.9% |
| ASRT | BUY | 2019-08-20 | 2019-08-20 | $1.50 | $21K | +2.1% | -6.4% | -40.9% |
| ASRT | BUY | 2019-08-12 | 2019-08-20 | $1.57 | $31K | +2.1% | -6.4% | -40.9% |
| ASRT | BUY | 2019-08-12 | 2019-08-12 | $1.54 | $3K | -1.3% | -10.4% | -53.4% |
| ASRT | BUY | 2019-03-14 | 2019-03-18 | $4.18 | $25K | +11.8% | -1.4% | -30.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.